A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of BIA 9-1067 on the levodopa
pharmacokinetics when administered in combination with immediate release levodopa/carbidopa
or levodopa/benserazide in Parkinson's Disease (PD) patients.